Common Contracts
15 similar Change in Control Severance Agreement contracts by Ardelyx, Inc.
ARDELYX, INC. CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • August 6th, 2020 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Susan Rodriguez (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as May 18, 2020 (the “Effective Date”).
ARDELYX, INC. CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • August 6th, 2020 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Justin Renz (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as June 8, 2020 (the “Effective Date”).
ARDELYX, INC. SECOND AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • May 8th, 2018 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Second Amended and Restated Change in Control Severance Agreement (the “Agreement”) is made and entered into this 7th day of May 2018 by and between David P. Rosenbaum, Ph.D. (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as January 19, 2017 (the “Effective Date”). This Agreement amends and restates in its entirety that certain Amended and Restated Change in Control Severance Agreement by and between Executive and the Company effective as of June 6, 2014 (the “Prior Agreement”)
ARDELYX, INC. SECOND AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • May 8th, 2018 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Second Amended and Restated Change in Control Severance Agreement (the “Agreement”) is made and entered into this 7th day of May 2018 by and between Elizabeth Grammer (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as January 16, 2018 (the “Effective Date”). This Agreement amends and restates in its entirety that certain Amended and Restated Change in Control Severance Agreement by and between Executive and the Company effective as of June 6, 2014 (the “Prior Agreement”)
ARDELYX, INC. CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • February 17th, 2017 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Bryan Shaw (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as of the 6th day of December 2016 (the “Effective Date”).
ARDELYX, INC. CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • February 17th, 2017 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Reginald Kim Seeto, MB.BS; B.Sc (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as October 22, 2016 (the “Effective Date”).
ARDELYX, INC. CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • February 17th, 2017 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Paul Korner, MD, MBA (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as January 4, 2016 (the “Effective Date”).
ARDELYX, INC. CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • March 5th, 2015 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Jeremy S. Caldwell, Ph.D (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as December 1, 2014 (the “Effective Date”).
ARDELYX, INC. CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • March 5th, 2015 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Narani Arasaratnam (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).
ARDELYX, INC. AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • June 9th, 2014 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Amended and Restated Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Mark Kaufmann (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”). This Agreement amends and restates in its entirety that certain Change in Control Severance Agreement by and between Executive and the Company effective as of August 16, 2011 (the “Prior Agreement”).
ARDELYX, INC. AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • June 9th, 2014 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Amended and Restated Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between George T. Jue (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”). This Agreement amends and restates in its entirety that certain Change in Control Severance Agreement by and between Executive and the Company effective as of April 15, 2010 (the “Prior Agreement”).
ARDELYX, INC. AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • June 9th, 2014 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Amended and Restated Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Elizabeth Grammer (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”). This Agreement amends and restates in its entirety that certain Change in Control Severance Agreement by and between Executive and the Company effective as of March 4, 2013 (the “Prior Agreement”).
ARDELYX, INC. AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • June 9th, 2014 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Amended and Restated Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between David Rosenbaum, Ph.D. (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”). This Agreement amends and restates in its entirety that certain Change in Control Severance Agreement by and between Executive and the Company effective as of April 15, 2010 (the “Prior Agreement”).
ARDELYX, INC. CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • June 9th, 2014 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Dominique Charmot (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).
ARDELYX, INC. AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • June 9th, 2014 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Amended and Restated Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Jeffrey W. Jacobs, Ph.D. (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”). This Agreement amends and restates in its entirety that certain Change in Control Severance Agreement by and between Executive and the Company effective as of April 15, 2010 (the “Prior Agreement”).
